212 related articles for article (PubMed ID: 21098545)
21. Postprandial lipemia associates with liver fat content.
Matikainen N; Mänttäri S; Westerbacka J; Vehkavaara S; Lundbom N; Yki-Järvinen H; Taskinen MR
J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790
[TBL] [Abstract][Full Text] [Related]
22. Altering lipid patterns in adult males.
Appelbaum JJ; Amundsen MA; Perkin DK
J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
[No Abstract] [Full Text] [Related]
23. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome.
Tushuizen ME; Pouwels PJ; Bontemps S; Rustemeijer C; Matikainen N; Heine RJ; Taskinen MR; Diamant M
Atherosclerosis; 2010 Jul; 211(1):308-14. PubMed ID: 20227695
[TBL] [Abstract][Full Text] [Related]
24. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
[TBL] [Abstract][Full Text] [Related]
25. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
[TBL] [Abstract][Full Text] [Related]
26. Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia.
Kovar J; Havel RJ
J Lipid Res; 2002 Jul; 43(7):1026-34. PubMed ID: 12091486
[TBL] [Abstract][Full Text] [Related]
27. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
28. Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels.
Nakatani K; Sugimoto T; Masuda D; Okano R; Oya T; Monden Y; Yamashita T; Kawase R; Nakaoka H; Inagaki M; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Komuro I; Yamashita S
Atherosclerosis; 2011 Sep; 218(1):226-32. PubMed ID: 21641598
[TBL] [Abstract][Full Text] [Related]
29. Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia.
Verseyden C; Meijssen S; Castro Cabezas M
J Lipid Res; 2002 Feb; 43(2):274-80. PubMed ID: 11861669
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
31. Dietary diacylglycerol in a typical meal suppresses postprandial increases in serum lipid levels compared with dietary triacylglycerol.
Tomonobu K; Hase T; Tokimitsu I
Nutrition; 2006 Feb; 22(2):128-35. PubMed ID: 16459225
[TBL] [Abstract][Full Text] [Related]
32. Effects of magnesium on postprandial serum lipid responses in healthy human subjects.
Kishimoto Y; Tani M; Uto-Kondo H; Saita E; Iizuka M; Sone H; Yokota K; Kondo K
Br J Nutr; 2010 Feb; 103(4):469-72. PubMed ID: 19941679
[TBL] [Abstract][Full Text] [Related]
33. Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period.
Sato I; Ishikawa Y; Ishimoto A; Katsura S; Toyokawa A; Hayashi F; Kawano S; Fujioka Y; Yamashita S; Kumagai S
J Atheroscler Thromb; 2009 Mar; 16(1):12-20. PubMed ID: 19262003
[TBL] [Abstract][Full Text] [Related]
34. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
[No Abstract] [Full Text] [Related]
35. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
Saniabadi AR; Umemura K; Shimoyama M; Adachi M; Nakano M; Nakashima M
Thromb Haemost; 1997 May; 77(5):996-1001. PubMed ID: 9184417
[TBL] [Abstract][Full Text] [Related]
36. Resistance exercise but not aerobic exercise lowers remnant-like lipoprotein particle cholesterol in type 2 diabetes: a randomized controlled trial.
Gavin C; Sigal RJ; Cousins M; Menard ML; Atkinson M; Khandwala F; Kenny GP; Proctor S; Ooi TC;
Atherosclerosis; 2010 Dec; 213(2):552-7. PubMed ID: 20870234
[TBL] [Abstract][Full Text] [Related]
37. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
Padilla N; Maraninchi M; Béliard S; Berthet B; Nogueira JP; Wolff E; Nicolay A; Bégu A; Dubois N; Grangeot R; Mattei C; Vialettes B; Xiao C; Lewis GF; Valéro R
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
[TBL] [Abstract][Full Text] [Related]
39. n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes.
Tremblay AJ; Lamarche B; Hogue JC; Couture P
J Diabetes Res; 2016; 2016():2909210. PubMed ID: 27034958
[TBL] [Abstract][Full Text] [Related]
40. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.
Nakajima K; Tanaka A
Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
